Bionexus Gene Lab Corp Asset Turnover Ratio (BGLC), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bionexus Gene Lab Corp   (NASDAQ: BGLC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Bionexus Gene Lab Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2026, Bionexus Gene Lab 's asset turnover ratio sequentially decreased to 0.35 in the second quarter (Jun 30 2026), this is lower than usual.

Within sector 23 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2753 to 2771.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BGLC Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 6.78 % -4.64 % -11.32 % -34.77 % -26.67 %
Y / Y Revenue Change -96.63 % -98.93 % -80.83 % -3.29 % 14.47 %
Asset Turnover Ratio (TTM) 0.35 0.6 0.83 1.02 0.93
BGLC's Total Ranking # 2771 # 2753 # 1157 # 858 # 918
Seq. Asset Change 11.28 % -2.3 % 20.59 % -18.56 % -0.62 %
Seq. Revenue Change 233.4 % -95.28 % -80.98 % 12.55 % 5.76 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 24
Healthcare Sector # 400
Overall Market # 2771

Asset Turnover Ratio Statistics
High Average Low
811.28 115.68 3.65
(Sep 30 2021)   (Mar 31 2023)




BGLC Company Profile • Back to BGLC Efficiency Comparisons • Compare BGLC Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Amneal Pharmaceuticals Inc   0.85 $ 3,117.474  Millions$ 3,648.680  Millions
Vivos Therapeutics Inc   0.85 $ 21.135  Millions$ 24.996  Millions
Alpha Pro Tech Ltd   0.84 $ 62.204  Millions$ 74.083  Millions
Healthlynked Corp  0.82 $ 1.372  Millions$ 1.671  Millions
West Pharmaceutical Services Inc   0.80 $ 3,326.900  Millions$ 4,140.500  Millions
Davita Inc   0.80 $ 14,009.646  Millions$ 17,561.212  Millions
Airsculpt Technologies Inc   0.79 $ 150.724  Millions$ 189.626  Millions
Concentra Group Holdings Parent Inc   0.79 $ 2,287.465  Millions$ 2,900.588  Millions
Nexgel Inc   0.79 $ 11.810  Millions$ 15.032  Millions
Iradimed Corporation  0.76 $ 86.339  Millions$ 113.215  Millions
Lifeward ltd   0.76 $ 21.822  Millions$ 28.622  Millions
Msa Safety Inc  0.76 $ 1,946.916  Millions$ 2,568.362  Millions
Harmony Biosciences Holdings inc   0.75 $ 960.191  Millions$ 1,281.189  Millions
Novocure Limited  0.75 $ 699.193  Millions$ 937.159  Millions
Verrica Pharmaceuticals Inc   0.74 $ 30.321  Millions$ 40.707  Millions
Staar Surgical Co  0.74 $ 339.590  Millions$ 458.591  Millions
Adapthealth Corp   0.74 $ 3,226.709  Millions$ 4,366.244  Millions
Journey Medical Corp  0.74 $ 68.181  Millions$ 92.417  Millions
Biomerica Inc   0.73 $ 4.453  Millions$ 6.109  Millions
Tenet Healthcare Corp  0.72 $ 21,812.000  Millions$ 30,243.500  Millions
Neurocrine Biosciences Inc   0.70 $ 3,373.900  Millions$ 4,790.625  Millions
Establishment Labs Holdings Inc   0.70 $ 245.105  Millions$ 349.756  Millions
Quest Diagnostics Inc  0.70 $ 11,560.000  Millions$ 16,508.500  Millions
Jaguar Health Inc   0.70 $ 27.815  Millions$ 39.856  Millions
Pulmonx Corporation  0.70 $ 87.393  Millions$ 125.568  Millions
Gyre Therapeutics Inc   0.70 $ 119.383  Millions$ 171.697  Millions
3m Company  0.69 $ 25,180.000  Millions$ 36,426.000  Millions
Illumina Inc   0.69 $ 4,493.000  Millions$ 6,507.500  Millions
Neuraxis Inc   0.69 $ 5.316  Millions$ 7.731  Millions
Harrow Inc   0.69 $ 274.724  Millions$ 399.729  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.